Menu
GeneBe

TGM3

transglutaminase 3, the group of Transglutaminases

Basic information

Region (hg38): 20:2296000-2341079

Links

ENSG00000125780NCBI:7053OMIM:600238HGNC:11779Uniprot:Q08188AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • uncombable hair syndrome (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Uncombable hair syndrome 2ARGeneralThe clinical relevance of the condition is unclearDermatologic27866708

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TGM3 gene.

  • Inborn genetic diseases (29 variants)
  • not provided (9 variants)
  • TGM3-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TGM3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
4
clinvar
5
missense
27
clinvar
3
clinvar
2
clinvar
32
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
0
Total 0 0 27 4 6

Variants in TGM3

This is a list of pathogenic ClinVar variants found in the TGM3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-2309687-C-A TGM3-related disorder Benign (Apr 16, 2019)3060440
20-2309690-C-G TGM3-related disorder Likely benign (Nov 21, 2022)3030119
20-2309727-C-T TGM3-related disorder Likely benign (Jun 26, 2020)3038978
20-2309772-A-C not specified Uncertain significance (Mar 11, 2024)3176728
20-2310205-C-T not specified Uncertain significance (Jan 18, 2022)2271826
20-2310232-G-A not specified Uncertain significance (Oct 05, 2021)2230865
20-2310319-T-C not specified Uncertain significance (Aug 10, 2021)2242812
20-2310324-C-T not specified Likely benign (Jun 24, 2022)2320744
20-2310333-A-G not specified Uncertain significance (May 03, 2023)2565838
20-2311037-G-A not specified Uncertain significance (Aug 30, 2022)2366294
20-2311059-A-G not specified Uncertain significance (Oct 28, 2023)3176738
20-2311070-G-A not specified Uncertain significance (Jul 20, 2021)2400991
20-2311076-A-C TGM3-related disorder Benign (Nov 25, 2019)3060634
20-2311089-G-A not specified Uncertain significance (May 04, 2023)2543524
20-2312908-A-G not specified Likely benign (Mar 13, 2023)2495631
20-2312979-G-A not specified Uncertain significance (Feb 10, 2022)2412130
20-2317065-C-T TGM3-related disorder Likely benign (Dec 09, 2019)3042869
20-2317113-G-A not specified Uncertain significance (Feb 16, 2023)2486181
20-2317144-G-A TGM3-related disorder Benign (Nov 12, 2019)3061032
20-2317376-C-T not specified Uncertain significance (Aug 03, 2021)2390286
20-2317415-C-A Benign (Jun 22, 2018)785648
20-2317416-G-A not specified Uncertain significance (Jul 20, 2021)2238506
20-2317441-C-T TGM3-related disorder Likely benign (Apr 05, 2019)3047522
20-2317456-C-A not specified Uncertain significance (Jan 23, 2024)3176739
20-2325900-C-G TGM3-related disorder Benign/Likely benign (Feb 17, 2020)710153

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TGM3protein_codingprotein_codingENST00000381458 1345078
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002970.9991256950521257470.000207
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4114474231.060.00002674568
Missense in Polyphen159163.060.975121815
Synonymous-1.181981781.110.00001271363
Loss of Function2.981533.70.4460.00000178342

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002970.000297
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.000.00
European (Non-Finnish)0.0002930.000290
Middle Eastern0.0001630.000163
South Asian0.0002290.000229
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the calcium-dependent formation of isopeptide cross-links between glutamine and lysine residues in various proteins, as well as the conjugation of polyamines to proteins. Involved in the formation of the cornified envelope (CE), a specialized component consisting of covalent cross-links of proteins beneath the plasma membrane of terminally differentiated keratinocytes. Catalyzes small proline-rich proteins (SPRR1 and SPRR2) and LOR cross-linking to form small interchain oligomers, which are further cross-linked by TGM1 onto the growing CE scaffold (By similarity). In hair follicles, involved in cross- linking structural proteins to hardening the inner root sheath. {ECO:0000250}.;
Disease
DISEASE: Uncombable hair syndrome 2 (UHS2) [MIM:617251]: A form of uncombable hair syndrome, a condition characterized by scalp hair that is impossible to comb due to the haphazard arrangement of the hair bundles. A characteristic morphologic feature is a triangular to reniform to heart shape on cross-sections, and a groove, canal or flattening along the entire length of the hair. Most individuals are affected early in childhood and the hair takes on a spun-glass appearance with the hair becoming dry, curly, glossy, lighter in color, and progressively uncombable. The hair growth rate can range from slow to normal, and the condition improves with age. {ECO:0000269|PubMed:27866708}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.219

Intolerance Scores

loftool
0.320
rvis_EVS
-0.21
rvis_percentile_EVS
37.76

Haploinsufficiency Scores

pHI
0.360
hipred
N
hipred_score
0.380
ghis
0.408

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.538

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tgm3
Phenotype
homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
cellular protein modification process;peptide cross-linking;keratinocyte differentiation;hair follicle morphogenesis;keratinization;cell envelope organization;protein tetramerization
Cellular component
cytoplasm;extrinsic component of cytoplasmic side of plasma membrane;extracellular exosome
Molecular function
protein-glutamine gamma-glutamyltransferase activity;catalytic activity;calcium ion binding;transferase activity, transferring acyl groups